Clinical Trials List
2022-05-01 - 2023-07-21
Phase II/III
Recruiting2
Terminated6
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Pei-Chang Lee 無
- 王苑貞 無
- I-Cheng Lee 無
- Chin-Sung Kuo 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wan-Long Chuang 無
- 黃駿逸 無
- Chia-Yen Dai 無
- Ming-Lun Yeh 無
- Chung-Feng Huang 無
- Jee-Fu Huang 無
- 梁博程 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱彥程 無
- Chiu Hung Chiu 無
- 簡世杰 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 劉彥君 無
- 戴達英 無
- I-Shyan Sheen 無
- 滕威 無
- Rong-Nan Chien 無
- Chun-Yen Lin 無
- 鄭雅婷 無
- 林伯庭 無
- Wen-Juei Jeng 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蘇東弘 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tiong Cheng 無
- 黃奕文 無
- Chun-Chao Chang 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12~20 participants
-
Global
1860 participants
